Midiana Zilnic (Drospirenone, Ethinylestradiol | Lactose Anhydrous)

• Midiana Zilnic, a combined oral contraceptive, is used within the hormonal contraception pathway to prevent pregnancy.
• Prevention of pregnancy: provides reliable contraception for women of reproductive age.
• Menstrual cycle regulation: helps achieve more regular and predictable bleeding patterns.
• Acne treatment: may improve mild to moderate acne associated with hormonal fluctuations.

• Drospirenone and ethinylestradiol act together to suppress the hypothalamic‑pituitary‑ovarian axis, reducing the secretion of luteinizing hormone (LH) and follicle‑stimulating hormone (FSH). This inhibition prevents follicular development and ovulation. In addition, the progestogenic component thickens cervical mucus and the estrogen component stabilises the endometrial lining, creating conditions that are unfavorable for fertilisation and implantation.

Midiana Zilnic may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects

• Nausea or gastrointestinal discomfort
• Breast tenderness or enlargement
• Headache or migraine
• Weight gain or fluid retention
• Mood changes or irritability
• Spotting or breakthrough bleeding

Serious or Rare Side Effects

• Venous thromboembolism (deep‑vein thrombosis, pulmonary embolism)
• Stroke or transient ischemic attack
• Myocardial infarction or other arterial thrombosis
• Severe hypertension or hypertensive crisis
• Liver disorders (cholestasis, hepatic adenoma)
• Anaphylaxis or severe allergic reactions

• Before prescribing Midiana Zilnic, clinicians should evaluate individual risk factors and counsel patients on safe use.
• Thrombotic risk assessment: review personal and family history of clotting disorders.
• Smoking restriction: avoid use in women who smoke >15 cigarettes per day.
• Liver disease evaluation: contraindicated in active or severe hepatic impairment.
• Blood pressure monitoring: check for hypertension before initiation and periodically thereafter.
• Missed pill guidance: provide clear instructions on how to manage forgotten doses.
• Store at ambient temperature: keep below 25 °C in the original packaging, protected from moisture and light.

Midiana Zilnic can interact with several medicines that affect its hormonal components or metabolism.

Major Interactions (Avoid)

• Strong CYP3A4 inducers (e.g., rifampin, carbamazepine, phenytoin)
• Certain antiretrovirals (e.g., efavirenz, nevirapine)
• St. John's wort (hypericum perforatum)

Moderate Interactions (Monitor Closely)

• Antifungal agents (e.g., ketoconazole, itraconazole)
• Certain antibiotics (e.g., tetracycline, doxycycline)
• Herbal supplements (e.g., ginkgo biloba, garlic preparations)